Direktorat Registrasi ObatValid

ATORVASTATIN CALCIUM TRIHYDRATE

BPOM Number: GKL1938202509A1
Approved: 23 June 2026
Expiry: 29 May 2031
Form: KAPLET SALUT SELAPUT

About This Registration

ATORVASTATIN CALCIUM TRIHYDRATE is a BPOM-registered direktorat registrasi obat in Indonesia, registered under number GKL1938202509A1. Its current registration status is Valid, with the licence valid until 29 May 2031. The product is registered to PHARMA HEALTH CARE and manufactured by PHARMA HEALTH CARE - INDONESIA. BPOM first approved this registration in May 2026. All registration data is sourced directly from the official BPOM public database and updated daily.

Registration data updated by BPOM

This product's registration details were changed on 1 July 2026. This may reflect a status change, renewal, or correction by BPOM.

Registration Details

Application: newaero
Packaging: DUS, 10 STRIP @ 10 KAPLET SALUT SELAPUT
Department: Direktorat Registrasi Obat
Data Last Updated: 1 July 2026

Retail Audit Service

Get detailed market intelligence for this product across Indonesian retail channels

Multiple cities available

Custom questionnaires

Professional shoppers

Detailed reporting

Starting from $50 per city

What's included in the audit service?

Stock availability and positioning verification

Price checking and competitor analysis

Display quality and promotional material assessment

Store condition and customer experience evaluation

Custom questions tailored to your research needs

Professional photographs and detailed reports

Registered Owners

PHARMA HEALTH CARE
Kab. Bandung Barat, Jawa Barat, Indonesia
NPWP: 024669780056000
owner
View profile →

Manufacturing Sites

PHARMA HEALTH CARE - INDONESIA
KAB. BANDUNG BARAT
primary
View profile →

Ingredients (1)

ATORVASTATIN CALCIUM TRIHYDRATE

Market Intelligence

Owner Portfolio: PHARMA HEALTH CARE holds 22 BPOM registrations
Manufacturer Scale: PHARMA HEALTH CARE - INDONESIA produces 16 registered products
Registration Age: Registered for 3 months
Update Status: Recently updated (70 days ago)

FDA Cross-Reference

via openFDA

Generic Name: ATORVASTATIN CALCIUM
Product Type: HUMAN PRESCRIPTION DRUG
Route of Administration: ORAL

Data sourced from the U.S. FDA drug label database (openFDA). May not exactly match this product variant.

Is this your product?